Implant Types Used in Korea
가슴성형 (gaseum seonghyeong, breast cosmetic surgery) in Korea is performed almost exclusively with silicone-based implants. Saline implants — once common in the US market — represent a small minority of placements at Korean clinics, primarily used when a patient specifically requests them or when a minor intraoperative volume adjustment is needed.
The dominant device is the cohesive silicone gel implant, colloquially called a “gummy bear” implant because the cross-linked gel holds its shape if the shell is cut. Korean clinics stock devices from global manufacturers (Mentor, Allergan/Natrelle) and Korean manufacturers including Hans Biomed and Hugel, all requiring approval from the MFDS (식약처, Sikgyacheo) — Korea’s Ministry of Food and Drug Safety, the regulatory body equivalent to the US FDA.
Three implant categories are in routine use:
| Type | Fill material | Texture | Typical projection | Typical cost premium | Risk profile note |
|---|---|---|---|---|---|
| Cohesive gel — round | Cross-linked silicone gel | Smooth (most common) or textured | Moderate to high; multiple profiles available | Base price; no premium | Lower shell failure rate than older gel devices; capsular contracture remains primary long-term risk |
| Cohesive gel — anatomical (teardrop) | Highly cross-linked silicone gel | Textured (required for positional stability) | Tapered upper pole, fuller lower pole | ₩500K–1M (≈$370–740) above round | Textured surface associated with BIA-ALCL risk (extremely rare); rotation risk if capsule forms loosely |
| Saline | Sterile saline solution | Smooth or textured | Moderate; less adjustable post-fill | Typically lower or equivalent | Visible rippling more likely in thin-tissue patients; deflation is detectable immediately |
Round vs. anatomical: Round implants remain the most placed device in Korea. They produce symmetric fullness in all orientations and carry no rotation risk. Anatomical implants suit patients seeking a more graduated upper-pole slope — a natural resting breast contour — but require textured shells, which carry a documented (though statistically rare) association with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Discuss this trade-off explicitly with your surgeon before choosing an anatomical device.
Plastic surgery and dermatology collectively account for the largest share of procedures sought by international patients visiting Korea,² making implant supply chains at Seoul clinics well-established and consistently stocked with current-generation devices.
Placement Techniques: Subglandular, Submuscular, Dual-Plane
The implant pocket — the anatomical space the surgeon creates to house the implant — determines how natural the result looks and how the breast ages over time. Three placements are used in Korea:
Subglandular (over the muscle): The implant sits between the breast gland and the pectoral (chest) muscle. Recovery is faster and post-operative muscle movement does not distort the implant. The tradeoff: in patients with thin soft tissue cover — minimal native breast tissue or low body fat — rippling and implant edges are more visible, and mammography interpretation is marginally more complex. Subglandular placement suits patients with moderate-to-good existing breast tissue who want a quicker recovery.
Submuscular (under the muscle, full coverage): The implant sits beneath the pectoralis major muscle entirely. Soft tissue coverage is maximised, reducing visible rippling. The downside is a longer, more uncomfortable recovery — the muscle must be elevated, causing notable tightness for 2–4 weeks — and dynamic distortion (the implant shifts when the pectoral muscle contracts) affects a subset of patients long-term.
Dual-plane (partial submuscular): The most commonly recommended technique at Korean aesthetic clinics for patients with thin tissue. The upper two-thirds of the implant sits under the muscle; the lower pole is subglandular. This geometry provides the rippling-reduction benefit of submuscular placement where it matters most (upper pole, décolletage) while allowing the lower pole to sit more naturally and reducing muscle-animation distortion. Dual-plane also permits the surgeon to address mild ptosis (drooping) by adjusting the plane boundary — a meaningful advantage for patients with some degree of breast sag who are not candidates for a concurrent lift.
Three factors typically determine which plane your surgeon recommends: the thickness of your existing tissue cover, your degree of ptosis, and your occupation (patients in physical jobs or sports requiring strong pectoral use may prefer subglandular to avoid animation distortion).
Candidacy: Who Suits Breast Augmentation in Korea
Often a good candidate
- Adults aged 20+ with fully developed breasts and stable anatomy
- Weight stable for 12+ months — significant fluctuation post-surgery alters the result
- Realistic expectations for size and shape improvement, not perfection
- Non-smokers, or ex-smokers with 6+ weeks cessation before surgery
- Able to stay in Seoul a minimum of 10 days for drain removal and post-operative review
- General health adequate for general anaesthesia — no uncontrolled systemic conditions
Should reconsider or wait
- Active smokers: nicotine impairs wound healing, increases capsular contracture (scar tissue hardening around the implant) risk, and elevates anaesthetic risk — cessation is required
- Patients with significant ptosis (drooping) who may need a concurrent mastopexy (lift); augmentation alone will not correct the position of a descended nipple
- First-degree relative history of BRCA-related breast cancer: discuss pre-surgical imaging and genetic screening with your GP before proceeding
Not a suitable candidate
- Patients who are pregnant or breastfeeding
- Patients with active breast infection or unresolved breast pathology (lumps, calcifications under investigation)
- Patients with unrealistic expectations around maximum possible size — overlarge implants relative to chest width increase long-term complications including bottoming out and skin thinning
Korea’s KSPRS (대한성형외과학회, Daehan Seonghyeong Oegwa Haghoe) — the Korean Society of Plastic and Reconstructive Surgeons, South Korea’s official certification board for plastic surgeons — requires board-certified surgeons to conduct a formal pre-operative assessment.¹ This assessment should include a tissue pinch test (measuring soft tissue thickness to determine pocket placement), implant sizer assessment, and a discussion of implant volume relative to base width — not cup size, which is a bra measurement, not an anatomical one.
International patients should complete any outstanding breast imaging (ultrasound or mammogram if indicated by age or history) before travelling, as organising imaging in Seoul adds time and cost.
Breast Augmentation Cost in Korea 2026
Four factors set the price range:
- Implant brand and type — Korean-manufactured cohesive gel implants (Hans Biomed, Hugel) sit at the lower end; global brands (Allergan, Mentor) carry a 10–20% premium. Anatomical implants add approximately ₩500K–1M (≈$370–740 / AUD$560–1,120) over round devices.
- Surgeon tier — Surgeons with 10+ years of dedicated breast experience at established Gangnam clinics command higher fees than junior surgeons at mid-tier clinics.
- Anaesthesia and facility fees — General anaesthesia (standard for breast augmentation) adds ₩300K–700K (≈$220–515 / AUD$340–785) depending on duration.
- Inclusion of post-operative care — Some clinics bundle drain removal, compression garment, and two follow-up reviews; others bill separately.
Indicative 2026 price bands (all-in surgical fee):
- Budget tier (mid-level clinic, Korean-brand implant): ₩3–4.5M (≈$2,200–3,300 / AUD$3,370–5,060)
- Mid tier (established Gangnam clinic, global-brand round implant): ₩4.5–6.5M (≈$3,300–4,780 / AUD$5,060–7,300)
- Senior surgeon tier (high-volume breast specialist, premium implant): ₩6.5–8M (≈$4,780–5,880 / AUD$7,300–8,990)
These fees do not include accommodation, flights, or translation services. Gangnam-gu receives approximately 60% of medical tourists seeking aesthetic procedures²; accommodation near clinics runs ₩100–250K per night (≈$75–185 / AUD$112–280) for a serviced apartment. A 10-night stay adds ₩1–2.5M (≈$735–1,840 / AUD$1,120–2,810) to the total trip cost.
Post-operative garments (compression bra) are typically supplied by the clinic or available locally for ₩50–150K (≈$37–110 / AUD$56–169).
Recovery Timeline: 6–8 Weeks to Full Activity
Recovery from breast augmentation in Korea follows a predictable sequence, though individual variation is significant depending on placement technique (submuscular recovery is slower than subglandular) and implant volume.
Days 1–2 (surgery and overnight): Most Korean clinics perform breast augmentation as day surgery or with one overnight stay. Drains — thin tubes placed in the pocket to prevent fluid accumulation — are inserted intraoperatively and remain in place for 2–5 days. Pain is managed with oral analgesia; the first 24–48 hours involve notable tightness and limited arm range of motion, particularly with submuscular or dual-plane placement.
Days 2–5 (drain removal): Drains are removed once output falls below the clinical threshold — typically 30ml per 24 hours. Drain removal is a clinic visit, not a surgical procedure. Walking is encouraged from day 1; lifting the arms above shoulder height is restricted.
Days 5–10 (early recovery): Bruising peaks around days 3–5 then fades. Swelling persists and will distort the final size appearance for 6–12 weeks — implants sit high and feel firm initially. Light walking and seated desk work are appropriate. No lifting over 2–3 kg.
Day 10–12 (fly home): Subject to drain removal confirmation and surgical clearance, international patients typically fly at day 10–12. Flying before day 7 without drain removal or a post-operative review is not recommended.
Weeks 3–6: Return to light exercise (lower body, walking). Avoid chest-loading movements — press-ups, swimming — until week 6 minimum.
Weeks 6–8: Full activity cleared for most patients. Final implant position settles at 3–6 months as the pocket relaxes.
Is breast augmentation cheaper in Korea than in Australia or the US?
Surgical fees for breast augmentation in Korea (₩3–8M / ≈$2,200–5,900 USD) are significantly lower than in the US ($6,000–12,000) and Australia (AUD$8,000–15,000). However, once flights and 10+ nights' accommodation are added, the saving narrows substantially — typically meaningful for patients from Australia (5–6 hour flight) and less clear-cut from North America.
Are breast implants in Korea FDA-approved?
Korea's implant regulator is the MFDS (식약처, Sikgyacheo), Korea's equivalent of the FDA. Korean clinics use MFDS-approved cohesive silicone gel implants from manufacturers including Mentor, Allergan, and Korean brands like Hans Biomed. These are not technically FDA-approved (FDA is a US body) but are certified to comparable Class III medical device standards. Confirm the specific implant brand and approval status with your clinic before surgery.
What is the minimum time I need to stay in Seoul after breast augmentation?
Most surgeons clear patients to fly at day 7–10, subject to drain removal (typically day 2–5) and satisfactory wound inspection. A minimum 10-day stay is realistic: surgery on day 1, drain removal days 2–5, second review day 7, flying day 10–12. Returning home before day 7 without drain removal or a post-operative review is not recommended.
How do I find a Korean surgeon who specialises in breast augmentation (not primarily facial surgery)?
Many Gangnam clinics are primarily facial surgery practices that also offer breast augmentation. Verify: the surgeon's KSPRS certification lists their subspecialty; ask the clinic what proportion of the surgeon's monthly caseload is breast procedures; request before/after portfolio specifically for breast augmentation cases. Surgeons performing 20+ breast procedures per month will have significantly more refined technique than those doing 1–2.